Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2026 Earnings Call Transcript

Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2026 Earnings Call Transcript May 6, 2026

Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-2.29 EPS, expectations were $-1.83.

Operator: Good day, and thank you for standing by. Welcome to the Revolution Medicines Q1 2026 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand it over to Ryan Asay, Senior VP of Corporate Affairs. Ryan, you have the...